Search

Search Constraints

You searched for: Author/Creator Kwiatkowski, David J.

Search Results

1. A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis. Issue 6 (27th June 2019)

2. Association of Early MRI Characteristics With Subsequent Epilepsy and Neurodevelopmental Outcomes in Children With Tuberous Sclerosis Complex. (22nd March 2022)

3. Association of Early MRI Characteristics With Subsequent Epilepsy and Neurodevelopmental Outcomes in Children With Tuberous Sclerosis Complex. (22nd March 2022)

4. Association of Early MRI Characteristics With Subsequent Epilepsy and Neurodevelopmental Outcomes in Children With Tuberous Sclerosis Complex. (22nd March 2022)

5. Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma. (16th February 2022)

6. Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial. Issue 5 (28th May 2020)

7. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Issue 3 (1st October 2014)

8. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Issue 3 (1st October 2014)

10. Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes. (29th March 2021)